Nociceptive Pain

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Presidio Medical
Presidio MedicalCA - South SF
1 program
ULF therapyN/A1 trial
Active Trials
NCT06763653RecruitingEst. Apr 2029

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
Presidio MedicalULF therapy

Clinical Trials (1)

NCT06763653Presidio MedicalULF therapy

Ultra Low Frequency Neuromodulation for Nociceptive Chronic Low Back Pain

Start: Jan 2025Est. completion: Apr 2029
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space